Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
53 studies found for:    parkinson's disease AND baylor
Show Display Options
Rank Status Study
21 Terminated NET-PD LS-1 Creatine in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: creatine;   Other: placebo
22 Active, not recruiting Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease
Conditions: Parkinson Disease;   Movement Disorders
Intervention: Device: Libra Deep Brain Stimulation System
23 Completed Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa
Condition: Idiopathic Parkinson's Disease
Interventions: Drug: Safinimide 50-100 mg/day;   Drug: Matching Placebo
24 Terminated
Has Results
Effects of Coenzyme Q10 (CoQ) in Parkinson Disease
Condition: Parkinson Disease
Interventions: Drug: Coenzyme Q10 with vitamin E;   Drug: placebo with vitamin E
25 Completed
Has Results
Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations
Condition: Parkinson's Disease
Interventions: Drug: 2 mg perampanel;   Drug: 4 mg perampanel;   Drug: placebo comparator
26 Terminated Efficacy and Safety Study of Aplindore in Patients With Early Parkinson Disease
Condition: Early Parkinson Disease
Intervention: Drug: aplindore MR tablets or Placebo
27 Recruiting Multiple Ascending Dose Study of PRX002 in Patients With Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: PRX002;   Other: Placebo
28 Recruiting National Parkinson Foundation Quality Improvement Initiative
Condition: Parkinson's Disease
Intervention:
29 Completed Impulse Control Disorders in Parkinson's Patients Treated With Pramipexole and Other Agents (DOMINION Study)
Condition: Parkinson Disease
Intervention:
30 Terminated Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease
Condition: Parkinson Disease
Interventions: Drug: CEP-1347 10mg;   Drug: CEP1347 25mg;   Drug: CEP-1347 50mg;   Other: Placebo Comparator
31 Completed A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa
Condition: Parkinson's Disease
Intervention: Drug: capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg)
32 Completed
Has Results
Double-Blind, Multicenter, Sham Surgery Controlled Study of CERE-120 in Subjects With Idiopathic Parkinson's Disease
Condition: Idiopathic Parkinson's Disease
Interventions: Genetic: CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN]);   Procedure: Sham Surgery
33 Completed
Has Results
Phase II Subthalamic Nucleus (STN) vs. Globus Pallidus (GPi) Trial
Condition: Parkinson's Disease
Intervention: Device: Bilateral Deep Brain Stimulation
34 Completed
Has Results
Phase I Deep Brain Stimulation (DBS) vs. Best Medical Therapy (BMT) Trial
Condition: Parkinson's Disease
Interventions: Device: Bilateral Deep Brain Stimulation;   Other: best medical therapy
35 Completed
Has Results
Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and Treatment
Condition: Parkinson's Disease
Interventions: Drug: Tigan®;   Drug: Placebo
36 Completed MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
Condition: Idiopathic Parkinson's Disease
Intervention: Drug: Safinamide (as add-on therapy)
37 Completed Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations
Condition: Parkinson's Disease
Interventions: Drug: rasagiline mesylate;   Drug: 1.0 mg rasagiline mesylate;   Other: Placebo
38 Completed Flu-Like Symptoms as a Complication of Botulinum Toxin Therapy
Condition: Flu-like Symptoms
Intervention:
39 Completed A Trial of Levodopa in Angelman Syndrome
Condition: Angelman Syndrome
Intervention: Drug: Levodopa/carbidopa
40 Completed
Has Results
A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa
Conditions: Symptomatic Neurogenic Orthostatic Hypotension (NOH);   Non-diabetic Neuropathy;   Primary Autonomic Failure;   Dopamine Beta Hydroxylase Deficiency
Interventions: Drug: Placebo;   Drug: Droxidopa

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-53) Show next page of results    Last Page
Indicates status has not been verified in more than two years